Medifast, Inc. (MED)
- Previous Close
26.36 - Open
26.90 - Bid 25.93 x 800
- Ask 26.00 x 1100
- Day's Range
25.82 - 28.44 - 52 Week Range
25.82 - 109.52 - Volume
641,742 - Avg. Volume
436,391 - Market Cap (intraday)
283.602M - Beta (5Y Monthly) 1.15
- PE Ratio (TTM)
4.19 - EPS (TTM)
6.19 - Earnings Date Apr 29, 2024
- Forward Dividend & Yield 6.60 (25.04%)
- Ex-Dividend Date Sep 18, 2023
- 1y Target Est
25.00
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
medifastinc.com634
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MED
Performance Overview: MED
Trailing total returns as of 5/2/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MED
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MED
Valuation Measures
Market Cap
288.31M
Enterprise Value
152.45M
Trailing P/E
4.26
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.32
Price/Book (mrq)
1.37
Enterprise Value/Revenue
0.17
Enterprise Value/EBITDA
1.62
Financial Highlights
Profitability and Income Statement
Profit Margin
7.55%
Return on Assets (ttm)
16.44%
Return on Equity (ttm)
35.49%
Revenue (ttm)
897.81M
Net Income Avi to Common (ttm)
67.76M
Diluted EPS (ttm)
6.19
Balance Sheet and Cash Flow
Total Cash (mrq)
156.43M
Total Debt/Equity (mrq)
9.75%
Levered Free Cash Flow (ttm)
56.58M
Research Analysis: MED
Company Insights: MED
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: MED
MED: Lowering target price to $29.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetMED: Raising target price to $35.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetMED: Lowering target price to $34.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetMED: Lowering target price to $36.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $36.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target